Aurora to Participate in the TD Cowen 46th Annual Health Care Conference

Core Insights - Aurora Cannabis Inc. will participate in the TD Cowen 46th Annual Health Care Conference on March 2, 2026, discussing its growth strategy and market opportunities [1] - The company has completed a transaction with Bevo Agtech Inc., enhancing its operational capabilities [1] Company Participation - Simona King, the Chief Financial Officer of Aurora, will engage in a fireside chat and one-on-one meetings with investors during the conference [1] - The discussion will cover Aurora's international leadership and the evolving global medical cannabis landscape [1] Market Position - Aurora is recognized as a global leader in medical cannabis, focusing on high-margin opportunities and a medical-first approach [1] - The company serves both medical and consumer markets across Canada, Europe, Australia, and New Zealand [1] Product and Brand Portfolio - Aurora's brand portfolio includes well-known names such as Aurora®, MedReleaf®, and Whistler Medical Marijuana Co.® [1] - The company operates GMP-certified manufacturing facilities in Canada and Germany, ensuring high-quality cannabis products [1]